Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Fulgent Genetics, Inc. Director's Dealing 2020

Feb 13, 2020

32553_dirs_2020-02-12_85dda575-931e-4e5d-a736-980387961729.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2019-12-31

Reporting Person: Hsieh Ming (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-10-23 Issuer Common Stock J 1315789 $0.00 Acquired 7895115 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Issuer Common Stock 0 Indirect
Issuer Common Stock 1000 Indirect
Issuer Common Stock 1000 Indirect

Footnotes

F1: On October 23, 2019, the Reporting Person transferred 1,315,789 shares of Common Stock of the Issuer held by the Ming Hsieh Annuity Trust established May 4, 2016, over which the reporting person possesses sole voting and dispositive power as the sole trustee, to himself as an individual.

F2: On November 30, 2017, the Reporting Person, acting as the custodian for his minor child under a Uniform Transfers to Minors Act ("UTMA") account, purchased 1,000 shares of the Issuer's Common Stock in an open market transaction at a weighted average price of $3.6042 per share.

F3: On November 30, 2017, the Reporting Person, acting as the custodian for his minor child under a UTMA account, purchased 1,000 shares of the Issuer's Common Stock in an open market transaction at a weighted average price of $3.6042 per share.